Inventor · disambiguated record
David G. Parkes
Also filed as: PARKES DAVID G · PARKES DAVID GEOFFREY
21 granted patents·10 pending applications·357 citations·filing 2005–2014
96Inventor score
Files withLEVY ODILE ESTHER8AMYLIN PHARMACEUTICALS INC6AMYLIN PHARMACEUTICALS LLC6LAUGERO KEVIN D3SOARES CHRISTOPHER J2
Top patents by PatentIndex Score
31 records- 0197US8076288B2Hybrid polypeptides having glucose lowering activityLEVY ODILE ESTHER·Filed 2005·Granted Dec 13, 2011·49 cites·7 claims
- 0296US8263545B2GIP analog and hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2007·Granted Sep 11, 2012·62 cites·3 claims
- 0395US8697647B2Hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2011·Granted Apr 15, 2014·15 cites·20 claims
- 0495US8497240B2DPP-IV resistant GIP hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2007·Granted Jul 30, 2013·25 cites·11 claims
- 0593US8114958B2Amylin family peptidesSOARES CHRISTOPHER J·Filed 2005·Granted Feb 14, 2012·24 cites·10 claims
- 0693US7879794B2Methods for controlling binge eating disordersAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Feb 1, 2011·28 cites·20 claims
- 0792US8603969B2Pancreatic polypeptide family motifs and polypeptides comprising the sameLEVY ODILE ESTHER·Filed 2005·Granted Dec 10, 2013·19 cites·3 claims
- 0892US7723471B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted May 25, 2010·18 cites·53 claims
- 0991US8278267B2Method of modifying food preference comprising administering amylin or amylin agonistWEYER CHRISTIAN·Filed 2010·Granted Oct 2, 2012·28 cites·6 claims
- 1090US8598120B2Methods for treatment using amylin family peptidesSOARES CHRISTOPHER J·Filed 2012·Granted Dec 3, 2013·14 cites·8 claims
- 1190US8426361B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameLEVY ODILE ESTHER·Filed 2009·Granted Apr 23, 2013·13 cites·6 claims
- 1290US8404637B2GIP analog and hybrid polypeptides with selectable propertiesLEVY ODILE ESTHER·Filed 2006·Granted Mar 26, 2013·16 cites·12 claims
- 1389US8263554B2Methods of using GLP-1 receptor agonists to treat pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2011·Granted Sep 11, 2012·18 cites·18 claims
- 1489US7671023B2Amylin agonist for treating depression, anxiety disorder and schizophreniaAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Mar 2, 2010·8 cites·3 claims
- 1587US8481490B2Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2012·Granted Jul 9, 2013·14 cites·4 claims
- 1676US8389477B2Amylin and amylin agonists for treating psychiatric diseases and disordersLAUGERO KEVIN D·Filed 2011·Granted Mar 5, 2013·2 cites·14 claims
- 1773US8309522B2Neuromedin and FN-38 peptides for treating psychiatric diseasesLAUGERO KEVIN D·Filed 2008·Granted Nov 13, 2012·3 cites·4 claims
- 1870US9133260B2GIP analog and hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Sep 15, 2015·1 cites·8 claims
- 1970US2010125054A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAMYLIN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2066US9453063B2Hybrid polypeptides with selectable propertiesAMYLIN PHARMACEUTICALS LLC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 2162US2015231204A1Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2260US8906849B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Dec 9, 2014·0 cites·8 claims
- 2359US2013184213A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersLAUGERO KEVIN D·Filed 2013·Application pending·0 cites
- 2459US2013225485A1Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating DisordersAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2555US8895498B2GIP and exendin hybrid polypeptidesLEVY ODILE ESTHER·Filed 2012·Granted Nov 25, 2014·0 cites·6 claims
- 2655US2009181890A1Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2748US2013281374A1Dpp-iv resistant gip hybrid polypeptides with selectable propertiesASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 2845US2013035294A1Neuromedin and FN-38 Peptides for Psychotic DiseasesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2944US2009286723A1Hybrid Polypeptides with Selectable PropertiesAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3041US2006094652A1Hybrid polypeptides with selectable propertiesLEVY ODILE E·Filed 2005·Application pending·0 cites
- 3128US2012071401A1Amylin agonist compounds for estrogen-deficient mammalsROTH JONATHAN DAVID·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David G. Parkes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →